Norwegian Gynecological Cancer Registry

The Norwegian Gynecological Cancer Registry contains data on ovarian, fallopian tube, and peritoneal cancer dating back to 2012, and data on cervical cancer dating back to 2019.
Last updated: 8/31/2022

The annual report from the National Quality Register for Gynecological Cancer Registry (GKR) contains data on ovarian cancer, fallopian tube cancer, peritoneal cancer (collective name ovarial cancer) and cervical cancer. See figure 1.1 and figure 1.3 for an overview of national quality indicators and results. The proportion of patients among ovarian cancer having surgery differs from 70,4 % to 83,8 % between health regions. The registry has set a goal for the proportion of patients that should undergo surgery at 80 %.

In 2021, 86,4 % of ovarial cancer patients underwent surgery at a regional hospital specializing in gynaecological cancer. The reason for centralizing treatment at regional specialist centers is to ensure quality of care and cost- effectiveness.

Over the last three years, the postoperative mortality rate up to 60 days following surgery was 0,8 % for the whole country in ovarial cancer, a slight decrease from the previous year. This is within the quality target that is set to no more than 3 % postoperative mortality. The postoperative mortality rate for up to one year following surgery is 6,1 % for the last three years merged. The total mortality rate for all ovarial cancer patients one year after diagnosis is 17,8 %, including patients that did not receive surgery.

The relative 5-year survival in ovarial cancer has increased in all age groups since the 1980s. During the last four decades, survival has increased by 19,4 % and is now 50,6 %. For cervical cancer, the 5-year survival has also in- creased during the last decades and are now 82,6 %.

Neoadjuvant chemotherapy was given to 24,4 % of the ovarial cancer patients who underwent surgery.

In 2021, 92,6 % of cancer registration forms regarding surgery for ovarial cancer were reported to the registry. The completeness of the clinical data in the registry has been through a very positive development. The quality goal for reporting to the registry is set at 80 %. It is still important to continue improving the completeness, even if we achieve the quality goals. The completeness of clinical data on cervical cancer has improved greatly since last year and reach the quality goal for the investigation form for the first time this year. The clinical reporting of cervical cancer will continue to be an important area of improvement for the registry.